ATC2015: Belatacept in Kidney Transplantation
There were several abstracts presented about outcomes in patients treated with belatacept, a recently FDA-approved immunosuppressive agent that blocks T-cell activation. [...]
ATC2015
ATC2015: Antibodies and Allograft Injury
There were two fascinating talks about the use of C1q modified Luminex assay to assess for complement fixing antibodies both before and after kidney transplantation. Prior [...]
ATC2015: Biomarkers in Transplantation
Biomarkers are always a hot topic in transplantation. At the ATC, Dr. Barbara Murphy, from the Icahn School of Medicine at Mt. Sinai, gave an intriguing discussion on [...]
ATC2015: Blocking B7 in Kidney Transplantation, Is It Effective in Preventing FSGS?
The American Transplant Congress (ATC) is the joint annual meeting of the American Society of Transplant Surgeons (ASTS) and the American Society of Transplantation (AST) and [...]